Clinical Trial Update: Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Arimidex (anastrozole), Faslodex (fulvestrant), and Iressa (gefitinib) in women with breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Faslodex (fulvestrant)
• Iressa (gefitinib)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: BREAST CANCER | Phase 2 | Status: TERMINATED